Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Zidovudine may cause hair loss in advanced-stage HIV patients.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Early diagnosis is crucial for treating alopecia effectively.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Platelet-rich plasma may improve hair density in androgenetic alopecia patients.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Herbal medications might be safer and more effective for hair loss than synthetic treatments.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

People with alopecia areata often have lower vitamin D levels than healthy people.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

0.05% Betamethasone Dipropionate is the most effective topical treatment for alopecia areata.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.